RE:RE:RE:RE:Financials ! No comments ?Bunge wrote: I
StevenBirch wrote: A little gloomy Bunge.
As for the FDA I wonder what new info they may have gotten that we don't know about to grant the FTD approval? Update on solving the dosing glitch? More patients enrolled and treated? If so we could get updated on that soon.
Also the FTD is a boost for enrollment. We all assume it's a slam dunk that someone would choose our trial but probably not so. Now with the FTD we get even more credibility.
Management? One of the E's posted about the dosing problem in AstraZeneca's covid vaccine trial so it does happen. I wish they updated more often but ... And I wouldn't worry about the burn rate just yet, there are plenty of possible catalysts to get the price moving before any raise will be needed.
Hopefully that is before year end.
Bunge wrote: FDA Fast Track
COVID-19 Pandemic Update
Clinical study site status
Additional cancer indications
COVID-19 Research Update
Everything good except money burning out, no promotion, no media coverage, no new investor interest, hangover from botching dosage, still no confidence in management.
I think real LONGS are just frustrated and burned out too.
I can count a half dozen off the top of my head that don't even bother posting anymore.
Yeah, bit gloomy.
Just throwing out some theories why we’re 19 cents and not $1.19 with all those great headlines.
As I said, the real problem to this technology is the idiot style management, get rid of these fu?king idiots, we could easily see 10 times up garanteed before year end, it's all about investors' confidence..